• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

As of July 2025, FDA is posting notices in a Docket at www.regulations.gov. In these cases, the link for the notices will take you to the document posted at www.regulations.gov. We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 1316 Show All Page 2 of 27
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1266
Wheat fiber extract from wheat (Triticumaestivum) Feb 17, 2026 FDA has no questions (in PDF) (266 kB)
  1265
Saccharomyces cerevisiae "BY-1532" Dec 11, 2025 FDA has no questions (in PDF) (270 kB)
  1264
Lacticaseibacillus rhamnosus CGMCC18639 Dec 9, 2025 FDA has no questions (in PDF) (268 kB)
  1263
Heyndrickxia coagulans PTA-1273661 spore preparation Dec 9, 2025 FDA has no questions (in PDF) (223 kB)
  1262
2'-Fucosyllactose Apr 8, 2026 FDA has no questions (in PDF) (334 kB)
  1261
2'-Fucosyllactose Jan 26, 2026 FDA has no questions (in PDF) (300 kB)
  1260
Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Nov 18, 2025 FDA has no questions (in PDF) (261 kB)
  1259
Fungal oil (≥40% arachidonic acid (ARA)) from Mortierella alpina strain TKA-1 Jan 7, 2026 FDA has no questions (in PDF) (198 kB)
  1258
Lacto-N-tetraose Apr 16, 2026 FDA has no questions (in PDF) (296 kB)
  1257
2'-Fucosyllactose Apr 16, 2026 FDA has no questions (in PDF) (326 kB)
  1256
Lemna leaf protein
   (Resubmission of GRN 1160)
Feb 5, 2026 FDA has no questions (in PDF) (260 kB)
  1255
Mycelial biomass of Fusarium compactum CGMCC 41312 (fungal protein) Nov 18, 2025 FDA has no questions (in PDF) (251 kB)
  1254
Bovine plasma protein preparation Sep 29, 2025 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (123 kB)
  1253
Lycopene preparation produced by Saccharomyces cerevisiae JZL03 Jul 21, 2025 FDA has no questions (in PDF) (310 kB)
  1252
Saccharomyces cerevisiae "BY-1568" Sep 23, 2025 FDA has no questions (in PDF) (162 kB)
  1251
Saccharomyces cerevisiae expressing a gene encoding a cysteine-thiol lyase from Staphylococcus hominis (S. cerevisiae "OYR-290") Sep 23, 2025 FDA has no questions (in PDF) (164 kB)
  1250
Alternansucrase enzyme preparation produced by Escherichia coli expressing the gene encoding alternansucrase from Leuconostoc mesenteroides Sep 29, 2025 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (130 kB)
  1249
Ovalbumin produced by Trichoderma reesei ATCC 13631 Sep 16, 2025 FDA has no questions (in PDF) (206 kB)
  1248
Yeast biomass produced by Kluyveromyces marxianus CCTCC M 20211265 Sep 23, 2025 FDA has no questions (in PDF) (236 kB)
  1247
β-Lactoglobulin produced by Kluyveromyces lactis CCTCC M20241460 Sep 19, 2025 FDA has no questions (in PDF) (209 kB)
  1246
Saccharomyces cerevisiae BY-1248 Sep 22, 2025 FDA has no questions (in PDF) (172 kB)
  1245
Lactiplantibacillus plantarum DSM 21379 Aug 5, 2025 FDA has no questions (in PDF) (173 kB)
  1244
Lactiplantibacillus plantarum DSM 21380 Aug 5, 2025 FDA has no questions (in PDF) (174 kB)
  1243
Bacillus coagulans M2017813 spore preparation Aug 21, 2025 FDA has no questions (in PDF) (205 kB)
  1242
Short-chain fructooligosaccharides Jul 14, 2025 FDA has no questions (in PDF) (94 kB)
  1241
β-lactoglobulin produced by Aspergillus oryzae Sep 16, 2025 FDA has no questions (in PDF) (253 kB)
  1240
Lacticaseibacillus rhamnosus ATCC PTA-126815 Jul 8, 2025 FDA has no questions (in PDF) (92 kB)
  1239
Bifidobacterium animalis subsp. lactis PTA-126817 Jun 11, 2025 FDA has no questions (in PDF) (92 kB)
  1238
2'-fucosyllactose Jun 17, 2025 FDA has no questions (in PDF) (113 kB)
  1237
β-glucanase enzyme preparation produced by Talaromyces versatilis Sep 22, 2025 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (146 kB)
  1236
Algal oil (≥40% docosahexaenoic acid) from Aurantiochytrium limacinum H Sc-01 Jun 10, 2025 FDA has no questions; some uses may require a color additive listing (in PDF) (240 kB)
  1235
Bifidobacterium lactis CCTCC M 2014588 Sep 2, 2025 FDA has no questions (in PDF) (210 kB)
  1234
Sansho (Zanthoxylum piperitum) pepper extract Jul 14, 2025 FDA has no questions (in PDF) (86 kB)
  1233
Sansho (Zanthoxylum piperitum) pepper distillate Jul 8, 2025 FDA has no questions (in PDF) (85 kB)
  1232
Lacticaseibacillus paracasei DSM 28047 Aug 6, 2025 FDA has no questions (in PDF) (252 kB)
  1231
Bacillus velezensis PTA-127359 Jul 11, 2025 FDA has no questions (in PDF) (92 kB)
  1230
Vanillin preparation produced by Escherichia coli BL21(DE3) SI-VAN1 Jun 11, 2025 FDA has no questions (in PDF) (101 kB)
  1229
Levilactobacillus brevis ATCC SD-7285 Aug 15, 2025 FDA has no questions (in PDF) (149 kB)
  1228
β-casein produced by E. coli DSM 35048 Jun 13, 2025 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (79 kB)
  1227
Korean red ginseng (Panax ginseng C.A. Meyer) root extract Aug 21, 2025 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (116 kB)
  1226
Orange (Citrus sinensis) extract Jun 9, 2025 FDA has no questions (in PDF) (156 kB)
  1225
Sakura (Prunus speciosa) leaf distillate Jun 3, 2025 FDA has no questions (in PDF) (82 kB)
  1224
Sakura (Prunus serrulata Lindl.) flower extract Jun 3, 2025 FDA has no questions (in PDF) (89 kB)
  1223
Sakura (Prunus serrulata Lindl.) flower distillate Jun 3, 2025 FDA has no questions (in PDF) (84 kB)
  1222
Saccharomyces cerevisiae OYR-542 May 5, 2025 FDA has no questions (in PDF) (224 kB)
  1221
Heyndrickxia coagulans NRRL B-67744 Jun 9, 2025 FDA has no questions (in PDF) (101 kB)
  1220
Mycelial biomass from Pleurotus pulmonarius Aug 15, 2025 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (138 kB)
  1219
Recombinant bovine lactoferrin isolate produced by Komagataella phaffii M020 expressing the gene encoding bovine lactoferrin May 7, 2025 FDA has no questions (in PDF) (580 kB)
  1218
Bacillus subtilis NRRL 68054 Apr 29, 2025 FDA has no questions (in PDF) (192 kB)
  1217
Algal oil (≥40% docosahexaenoic acid) from Aurantiochytrium limacinum CCAP A1 May 7, 2025 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (202 kB)

Show All 

jump to page of 27 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-